TritonPoint Wealth’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,918
Closed -$361K 307
2025
Q3
$361K Sell
4,918
-205
-4% -$13.6K 0.03% 265
2025
Q2
$266K Sell
5,123
-26
-0.5% -$1.48K 0.02% 294
2025
Q1
$329K Sell
5,149
-420
-8% -$24.4K 0.03% 264
2024
Q4
$266K Hold
5,569
0.02% 288
2024
Q3
$317K Sell
5,569
-1,176
-17% -$67.4K 0.03% 259
2024
Q2
$353K Sell
6,745
-19
-0.3% -$833 0.03% 237
2024
Q1
$250K Sell
6,764
-10
-0.1% -$375 0.03% 289
2023
Q4
$250K Buy
+6,774
New +$255K 0.02% 300

Other funds holding HALO

TritonPoint Wealth's HALO Position: Q4 2025 in Review

TritonPoint Wealth sold out of Halozyme (HALO) in Q4 2025, closing a stake of 4,918 shares — an estimated $361K sold.

TritonPoint Wealth first reported a position in HALO in Q4 2023 and held it in 8 quarters. The position peaked at $361K in Q3 2025. 617 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • TritonPoint Wealth reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
  • TritonPoint Wealth sold 4,918 Halozyme shares in Q4 2025, an estimated $361K.
  • TritonPoint Wealth first reported a position in Halozyme in Q4 2023 and held it in 8 quarters.
  • TritonPoint Wealth's Halozyme position peaked at $361K in Q3 2025.
  • 617 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on TritonPoint Wealth's 13F filing for Q4 2025, filed 20 Jan 2026.